Key facts
- Mingdu Zhiyun’s last known valuation is $341.5M (May 2021).
- It has raised $33.6M; the latest was Later Stage VC in Jan 2026.
- Notable investors include Shenzhen Capital Group, Zheshang Venture Capital, China Merchants Venture Capital, Hangzhou Hi-Tech Financial Investment Group, CASH Capital — 13 tracked in total.
- Status: Privately Held (backing).
Investors
13+- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Mingdu Zhiyun
- ·The full record, as it builds
Funding rounds
No funding rounds for Mingdu Zhiyun are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mingdu Zhiyun
Developer of full life-cycle management technology designed for pharmaceutical companies. The company aims to provide solutions covering research and development, production, warehousing, and logistics, which offer pharmaceutical companies full life cycle solutions from R&D to production, enabling drug makers to simplify and increase the efficiency of the application, production, and registration of pharmaceutical products.
- Sector
- Information Technology
- HQ
- Hangzhou, China
- Founded
- 2017
- Employees
- 500
- Website
- mingdutech.com/
- Ownership
- Privately Held (backing)
Mingdu Zhiyun doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mingdu Zhiyun shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mingdu Zhiyun in its N-PORT filings yet. We sweep new filings monthly.